ZIO-101 (Darinaparsin)

DRUG3 trials

Sponsors

Alaunos Therapeutics

Conditions

Acute LeukemiaChronic Lymphoproliferative DiseaseChronic Myeloproliferative DiseaseLymphomaMultiple MyelomaPoor-risk Myelodysplasia (MDS)Solid Tumors

Phase 1

Study of ZIO-101 in Multiple Myeloma

CompletedNCT00303199

Alaunos TherapeuticsMultiple Myeloma

Start: 2006-01-31End: 2007-08-31Updated: 2012-07-19

A Phase I Trial of ZIO-101 in Solid Tumors

CompletedNCT00591396

Alaunos TherapeuticsSolid Tumors

Start: 2005-07-31End: 2008-07-31Updated: 2012-07-19

A Phase I Trial of ZIO-101 in Hematologic Cancers

CompletedNCT00592046

Alaunos TherapeuticsAcute Leukemia, Chronic Lymphoproliferative Disease, Chronic Myeloproliferative Disease +3

Start: 2005-05-31End: 2008-06-30Updated: 2012-07-19